We're passionate about the early detection of TBI

BrainScope is a medical neurotechnology company that is developing a new generation of hand-held, easy-to-use, non-invasive instruments designed to aid medical professionals in rapidly and objectively assessing Traumatic Brain Injury (TBI), including milder forms known as concussion.  BrainScope devices in development are based on a proprietary technology platform, which integrates databases of brainwave recordings with advanced digital signal processing, sophisticated algorithms, miniaturized hardware and disposable headset sensors.  BrainScope's unique devices are being created to meet a long-standing clinical need for improved early identification, staging and triage of head injured patients. 

Results from clinical studies utilizing BrainScope’s technology have been independently published through 15 articles in leading peer-reviewed neurotrauma and emergency medicine journals. 

BrainScope has been awarded more than $27 million of U.S. Department of Defense research contracts for the development of its TBI and concussion assessment technology and has received two awards from GE and the NFL through its Head Health Challenge I.  The company has received significant funding from private investors including Revolution (created by AOL co-founder Steve Case), Shaman Ventures, ZG Ventures, State of Maryland Venture Fund, Brain Trust Accelerator Fund, and Difference Capital.


board of directors

 
Daniel J. Moore Chairman

Daniel J. Moore
Chairman

Jean Case

Jean Case

Miles R. Gilburne  

Miles R. Gilburne
 

James B. Peake, M.D. LTG (Ret)

James B. Peake, M.D. LTG (Ret)

 
 
John M. Reher

John M. Reher

Michael E. Singer

Michael E. Singer

Gail R. Wilensky, Ph.D

Gail R. Wilensky, Ph.D

 

Management

 
Michael E. Singer  Chief Executive Officer

Michael E. Singer 
Chief Executive Officer

Andrew Holman Chief Commercial Officer

Andrew Holman
Chief Commercial Officer

Leslie S. Prichep, Ph.D Chief Scientific Officer

Leslie S. Prichep, Ph.D
Chief Scientific Officer

Laurie Silver Chief Financial Officer

Laurie Silver
Chief Financial Officer

 
 
Greg Mahowald Vice President of Engineering

Greg Mahowald
Vice President of Engineering

Doug Oberly Vice President of Clinical Affairs

Doug Oberly
Vice President of Clinical Affairs

 

scientific ADVISORY BOARD

 
James B. Peake, M.D. LTG (Ret.) Chairman

James B. Peake, M.D. LTG (Ret.)
Chairman

Peter John Dawson Andrews, M.D., MB ChB, FRCA

Peter John Dawson Andrews, M.D., MB ChB, FRCA

Daniel L. Cohen, M.D.

Daniel L. Cohen, M.D.

Ruben Echemendia, Ph.D.

Ruben Echemendia, Ph.D.

 
 
James M. Ecklund, M.D., F.A.C.S., Col. (Ret.)

James M. Ecklund, M.D., F.A.C.S., Col. (Ret.)

Dallas C. Hack, M.D., Col. (Ret.)

Dallas C. Hack, M.D., Col. (Ret.)

Daniel F. Hanley, M.D.

Daniel F. Hanley, M.D.

Geoffrey Ling, M.D., Ph.D., Col. (Ret.)

Geoffrey Ling, M.D., Ph.D., Col. (Ret.)

 
 
Ed Michelson, M.D. FACEP

Ed Michelson, M.D. FACEP

Dighton C. Packard, M.D.

Dighton C. Packard, M.D.

Steven Schachter, M.D.

Steven Schachter, M.D.

Andrew M. Tucker, M.D.

Andrew M. Tucker, M.D.

 

OUR INVESTORS


CLINICAL PARTNERS

 
 

DEVELOPMENT PARTNERS